Teleflex Incorporated (NYSE:TFX) Stock Position Lowered by Simplify Asset Management Inc.

Simplify Asset Management Inc. decreased its position in Teleflex Incorporated (NYSE:TFX) by 34.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,742 shares of the medical technology company’s stock after selling 6,666 shares during the quarter. Simplify Asset Management Inc.’s holdings in Teleflex were worth $2,268,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Avior Wealth Management LLC increased its holdings in shares of Teleflex by 190.6% in the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after buying an additional 101 shares in the last quarter. True Wealth Design LLC raised its position in shares of Teleflex by 16,600.0% during the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock worth $41,000 after purchasing an additional 166 shares during the period. IFP Advisors Inc lifted its holdings in shares of Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock valued at $55,000 after purchasing an additional 217 shares during the last quarter. Banque Cantonale Vaudoise boosted its position in shares of Teleflex by 184.8% in the 3rd quarter. Banque Cantonale Vaudoise now owns 225 shares of the medical technology company’s stock valued at $56,000 after purchasing an additional 146 shares during the period. Finally, Exchange Traded Concepts LLC increased its stake in Teleflex by 38.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock worth $61,000 after purchasing an additional 94 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Royal Bank of Canada lowered shares of Teleflex from an “outperform” rating to a “sector perform” rating and reduced their price objective for the company from $220.00 to $155.00 in a research note on Friday, February 28th. Bank of America lowered shares of Teleflex from a “neutral” rating to an “underperform” rating and decreased their price objective for the stock from $235.00 to $140.00 in a research note on Tuesday, March 4th. Raymond James downgraded shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. Truist Financial decreased their target price on Teleflex from $200.00 to $149.00 and set a “hold” rating for the company in a research report on Monday, March 3rd. Finally, Citizens Jmp lowered Teleflex from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 27th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, Teleflex currently has an average rating of “Hold” and an average price target of $182.63.

Teleflex Price Performance

TFX opened at $141.77 on Friday. The stock has a fifty day moving average price of $163.17 and a 200 day moving average price of $194.04. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 1 year low of $128.55 and a 1 year high of $249.91. The stock has a market cap of $6.57 billion, a price-to-earnings ratio of 28.19, a PEG ratio of 1.73 and a beta of 1.21.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.96%. Teleflex’s dividend payout ratio is currently 95.77%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.